Talk: Overview of TCM therapy and TCM classification of syndromes of diseases

Professor Lyu Aiping is Chair Professor & Dean of School of Chinese Medicine, Hong Kong Baptist University, Director of Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ) of HKBU, Director of Institute of Integrated Bioinformedicine & Translational Science (IBTS) of HKBU, Chair Professor in CACMS and Recipient of the National Science Fund for Distinguished Young Scholar in 2007.
He obtained his master’s and Ph.D. degrees from China Academy of Traditional Chinese Medicine (now called the China Academy of Chinese Medical Sciences, CACMS) in 1987 and 1997 respectively.  From 2006 to 2012, he was the Deputy Director of Institute of Basic Research in Clinical Medicine and the Director of Institute of Basic Theory of CACMS from 1999 to 2002.  In 2002-2006, Prof Lu was appointed as General Director, Jiangxi Herbfine Hi-tech Co. Ltd, one of four centres in China in the field of Traditional Chinese Medicine.
Being a renowned expert and academic in the field, Prof Lu has been appointed as Head & Spokesperson of the China Delegation, International Organization for Standardization Technical Committee on TCM (ISO/TC249) since 2009, and serves as Member of Medical Advisory Committee of National Natural Science Foundation of China, Member of Chinese Pharmacopoeia Commission and Vice-Chairman, Terminology of Traditional Chinese Medicine Sub-Committee, China National Committee for Terms in Sciences and Technologies.
His research interests focus on the clinical evaluation with RCT focusing on rheumatoid arthritis with TCM pattern diagnosis, standardization of Chinese medicine diagnosis, and research and development of new drugs.  Prof Lu has published more than 30 books and over 500 articles, including 200 articles in SCI journals such as Nature Medicine. Over the years, he obtained more than 60 patents from his research activities.